September 6th 2024
The August 2024 cardiology month in review highlights critical data from the European Society of Cardiology Congress 24 and the latest updates on finerenone.
Transcutaneous Vagus Nerve Stimulation Significantly Reduces Atrial Fibrillation
SAN FRANCISCO― Results of the TREAT-AF trial showed burden of AF was reduced by 85% at 6 months using transcutaneous electrical stimulation of the vagus nerve, vs a sham procedure; findings were showcased at the 40th HRS Scientific Sessions.